Yuval Harari, Executive VP of BioView, says that he chose to work with RSIP Vision for several reasons: RSIP Vision’s expertise in AI, experience in medical devices, and the short time to market requirements. BioView has implemented this solution in its Duet Image and Analysis systems at several leading hospitals in the USA and Europe. “The feedback from the clinical operators has been very positive. The customers noted the increased throughput of the testing and the very accurate results they received as compared to other available solutions. We look forward to continue to work with RISP Vision on additional projects to help us provide the most efficient and accurate solutions on our cell imaging systems.”

About RSIP Vision
RSIP Vision is a global leader in artificial intelligence, computer vision, and image processing technology. The company draws on a depth of knowledge and experience to provide customized services, sophisticated algorithms, and deep learning technology to businesses of all kinds, most notably medical devices, pharmaceuticals, and autonomous driving.

RSIP Vision develops practical AI modules that ensure precision, reduce time to market, cut costs, and free the core R&D team staff for other endeavors, saving significant time and money and giving businesses a real edge over the competition. RSIP Vision partners with customers on scientific research and development projects using customized algorithms in fields including physics, computer science, mathematics, biomedicine, and neuroscience.
RSIP Vision is headquartered in Jerusalem, with U.S. offices in San Jose, CA, and Boston, MA. More information is available on the company website: https://www.rsipvision.com/.

About BioView Ltd
Established in 2000, and led by an expert team of biologists, software engineers, and physicists, BioView develops, manufactures, and supplies cell imaging equipment, and analysis software to medical institutes and universities. BioView is a publicly traded company on the Tel Aviv Stock exchange, and currently has strategic collaborations underway with international scientific leaders and institutions. For more information about the BioView technology, and press related issues, please contact alan@bioview.co.il or visit our website at http://www.bioview.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

DeeDee Rudenstein
Propel Strategic Communications
+1 (267) 521-9654
Email >
Visit website